Biotechs Share Endocrine Enthusiasm
This article was originally published in Start Up
Executive Summary
Start-ups developing new drugs for rare cancers and other disorders characterized by excessive hormone production know successful treatments are likely to eventually find larger markets. Profiles of Atterocor, Crinetics Pharmaceuticals, and OctreoPharm Sciences.